Bone Involvement and Osteoporosis in Mastocytosis

被引：63

作者：

Rossini, Maurizio ^{[1
]}

Zanotti, Roberta ^{[1
]}

Viapiana, Ombretta ^{[1
]}

Tripi, Gaia ^{[1
]}

Orsolini, Giovanni ^{[1
]}

Idolazzi, Luca ^{[1
]}

Bonadonna, Patrizia ^{[1
]}

Schena, Donatella ^{[1
]}

Escribano, Luis ^{[1
]}

Adami, Silvano ^{[1
]}

Gatti, Davide ^{[1
]}

机构：

[1] Univ Verona, Policlin Borgo Roma, I-37134 Verona, Italy

来源：

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA | 2014年 / 34卷 / 02期

关键词：

Mastocytosis; Osteoporosis; Osteosclerosis; Fracture; Bone mineral density; Bone turnover markers; MAST-CELL DISEASE; SYSTEMIC MASTOCYTOSIS; MARROW MASTOCYTOSIS; RETROSPECTIVE ANALYSIS; HISTAMINE-RECEPTORS; INTERFERON-ALPHA; INDOLENT; OSTEOPENIA; FRACTURE; PAMIDRONATE;

D O I：

10.1016/j.iac.2014.01.011

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Bone involvement is frequent in patients with systemic mastocytosis. Osteoporosis is the most prevalent bone manifestation, but diffuse osteosclerosis or focal osteolytic or osteosclerotic lesions are not infrequent. The risk of osteoporotic fractures is high, especially at the spine and In men. Routine measurements of bone mineral density and vertebral, morphometry are warranted. The bone turnover markers indicate the involvement of complex bone metabolism in mastocytosis-related manifestations.. Bisphosphonates represent the first-line treatment for osteoporosis-related mastocytosis.

引用

页码：383 / +

页数：15

共 50 条

[1] Bone Disease in Mastocytosis
Orsolini, Giovanni
Viapiana, Ombretta
Rossini, Maurizio
Bonifacio, Massimiliano
Zanotti, Roberta
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2018, 38 (03) : 443 - +
[2] Zoledronic Acid in Osteoporosis Secondary to Mastocytosis
Rossini, Maurizio
Zanotti, Roberta
Viapiana, Ombretta
Tripi, Gaia
Idolazzi, Luca
Biondan, Marta
Orsolini, Giovanni
Bonadonna, Patrizia
Adami, Silvano
Gatti, Davide
AMERICAN JOURNAL OF MEDICINE, 2014, 127 (11) : 1127.e1 - 1127.e4
[3] Endocrine manifestations of systemic mastocytosis in bone
Greene, Loren Wissner
Asadipooya, Kamyar
Corradi, Patricia Freitas
Akin, Cem
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2016, 17 (03) : 419 - 431
[4] Management of Bone Health in Adult Mastocytosis
Degboe, Yannick
Nezzar, Coralie
Alary, Pauline
Maeva, Masson
Livideanu, Cristina Bulai
Laroche, Michel
CURRENT OSTEOPOROSIS REPORTS, 2025, 23 (01)
[5] Osteoporosis in Systemic Mastocytosis: A Scoping Review
Mauro, Giulia Letizia
Accomando, Jessica
Tomasello, Sofia
Duca, Adele
Mangano, Maria Silvia
de Sire, Alessandro
Vecchio, Michele
Scaturro, Dalila
MEDICINA-LITHUANIA, 2024, 60 (11):
[6] Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis
Rossini, M.
Zanotti, R.
Orsolini, G.
Tripi, G.
Viapiana, O.
Idolazzi, L.
Zamo, A.
Bonadonna, P.
Kunnathully, V.
Adami, S.
Gatti, D.
OSTEOPOROSIS INTERNATIONAL, 2016, 27 (08) : 2411 - 2421
[7] Mastocytosis-induced osteoporosis
Maier, G. S.
Percic, D.
Maus, U.
Kurth, A. A.
OSTEOLOGIE, 2013, 22 (02) : 136 - 139
[8] Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis
Rossini, Maurizio
Zanotti, Roberta
Bonadonna, Patrizia
Artuso, Anna
Caruso, Beatrice
Schena, Donatella
Vecchiato, Decio
Bonifacio, Massimiliano
Viapiana, Ombretta
Gatti, Davide
Senna, Gianenrico
Riccio, Annamaria
Passalacqua, Giovanni
Pizzolo, Giovanni
Adami, Silvano
BONE, 2011, 49 (04) : 880 - 885
[9] Interferon Alpha and Pamidronate in Osteoporosis with Fracture Secondary to Mastocytosis
Laroche, Michel
Livideanu, Christina
Paul, Carle
Cantagrel, Alain
AMERICAN JOURNAL OF MEDICINE, 2011, 124 (08) : 776 - 778
[10] Systemic mastocytosis and bone involvement in a cohort of 75 patients
Barete, S.
Assous, N.
de Gennes, C.
Grandpeix, C.
Feger, F.
Palmerini, F.
Dubreuil, P.
Arock, M.
Roux, C.
Launay, J. M.
Fraitag, S.
Canioni, D.
Billemont, B.
Suarez, F.
Lanternier, F.
Lortholary, O.
Hermine, O.
Frances, C.
ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (10) : 1838 - 1841

← 1 2 3 4 5 →